Clinical trials
Not yet recruiting Phase 2 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 2 |
| AbelZeta Inc. | 1 |
| Brown University | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Fox Chase Cancer Center | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
| Hematology department of the 920th hospital | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Luminary Therapeutics | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 14 |
| Lymphoma, B-Cell | 3 |
| Leukemia | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Recurrence | 2 |
| Anemia, Aplastic | 1 |
| Cardiotoxicity | 1 |
| Endocrine Gland Neoplasms | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.